TY - JOUR AU - Hesketh, P. J. PY - 2008 DA - 2008// TI - Chemotherapy-induced nausea and vomiting JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMra0706547 DO - 10.1056/NEJMra0706547 ID - Hesketh2008 ER - TY - STD TI - NCCN. Clinical Practice Guidelines in Oncology-Antiemesis-Version II. Available from: https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf. Accessed 25 Dec 2017. UR - https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf ID - ref2 ER - TY - JOUR AU - Hesketh, P. J. AU - Bohlke, K. AU - Lyman, G. H. AU - Basch, E. AU - Chesney, M. AU - Clark-Snow, R. A. AU - Danso, M. A. AU - Jordan, K. AU - Somerfield, M. R. AU - Kris, M. G. PY - 2016 DA - 2016// TI - Antiemetics: American Society of Clinical Oncology focused guideline update JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.64.3635 DO - 10.1200/JCO.2015.64.3635 ID - Hesketh2016 ER - TY - STD TI - Oncology JSoC. JSCO Clinical Practice Guidelines 2015 for Antiemesis. Available from: http://www.jsco-cpg.jp/item/29/index.html. Accessed 25 Dec 2017. UR - http://www.jsco-cpg.jp/item/29/index.html ID - ref4 ER - TY - JOUR AU - Geling, O. AU - Eichler, H. G. PY - 2005 DA - 2005// TI - Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.04.022 DO - 10.1200/JCO.2005.04.022 ID - Geling2005 ER - TY - JOUR AU - Gralla, R. AU - Lichinitser, M. AU - Van Der Vegt, S. AU - Sleeboom, H. AU - Mezger, J. AU - Peschel, C. AU - Tonini, G. AU - Labianca, R. AU - Macciocchi, A. AU - Aapro, M. PY - 2003 DA - 2003// TI - Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron JO - Ann Oncol VL - 14 UR - https://doi.org/10.1093/annonc/mdg417 DO - 10.1093/annonc/mdg417 ID - Gralla2003 ER - TY - JOUR AU - Aapro, M. S. AU - Grunberg, S. M. AU - Manikhas, G. M. AU - Olivares, G. AU - Suarez, T. AU - Tjulandin, S. A. AU - Bertoli, L. F. AU - Yunus, F. AU - Morrica, B. AU - Lordick, F. AU - Macciocchi, A. PY - 2006 DA - 2006// TI - A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdl137 DO - 10.1093/annonc/mdl137 ID - Aapro2006 ER - TY - JOUR AU - Eisenberg, P. AU - Figueroa-Vadillo, J. AU - Zamora, R. AU - Charu, V. AU - Hajdenberg, J. AU - Cartmell, A. AU - Macciocchi, A. AU - Grunberg, S. AU - Palonosetron, S. G. PY - 2003 DA - 2003// TI - Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron JO - Cancer VL - 98 UR - https://doi.org/10.1002/cncr.11817 DO - 10.1002/cncr.11817 ID - Eisenberg2003 ER - TY - JOUR AU - Uchida, M. AU - Mori, Y. AU - Nakamura, T. AU - Kato, K. AU - Kamezaki, K. AU - Takenaka, K. AU - Shiratsuchi, M. AU - Kadoyama, K. AU - Miyamoto, T. AU - Akashi, K. PY - 2017 DA - 2017// TI - Comparison between antiemetic effects of palonosetron and granisetron on chemotherapy-induced nausea and vomiting in Japanese patients treated with R-CHOP JO - Biol Pharm Bull VL - 40 UR - https://doi.org/10.1248/bpb.b17-00318 DO - 10.1248/bpb.b17-00318 ID - Uchida2017 ER - TY - JOUR AU - López-Jiménez, J. AU - Martín-Ballesteros, E. AU - Sureda, A. AU - Uralburu, C. AU - Lorenzo, I. AU - del Campo, R. AU - Fernández, C. AU - Calbacho, M. AU - García-Belmonte, D. AU - Fernández, G. PY - 2006 DA - 2006// TI - Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study JO - Haematologica VL - 91 ID - López-Jiménez2006 ER - TY - JOUR AU - Mattiuzzi, G. N. AU - Cortes, J. E. AU - Blamble, D. A. AU - Bekele, B. N. AU - Xiao, L. AU - Cabanillas, M. AU - Borthakur, G. AU - O'Brien, S. AU - Kantarjian, H. PY - 2010 DA - 2010// TI - Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25365 DO - 10.1002/cncr.25365 ID - Mattiuzzi2010 ER - TY - JOUR AU - Bonadonna, G. AU - Santoro, A. AU - Bonfante, V. AU - Valagussa, P. PY - 1982 DA - 1982// TI - Cyclic delivery of MOPP and ABVD combinations in stage IV Hodgkin's disease: rationale, background studies, and recent results JO - Cancer Treat Rep VL - 66 ID - Bonadonna1982 ER - TY - JOUR AU - Bonadonna, G. AU - Santoro, A. PY - 1982 DA - 1982// TI - ABVD chemotherapy in the treatment of Hodgkin's disease JO - Cancer Treat Rev VL - 9 UR - https://doi.org/10.1016/S0305-7372(82)80003-0 DO - 10.1016/S0305-7372(82)80003-0 ID - Bonadonna1982 ER - TY - JOUR AU - Jørgensen, M. AU - Victor, M. A. PY - 1996 DA - 1996// TI - Antiemetic efficacy of ondansetron and metoclopramide, both combined with corticosteroid, in malignant lymphoma patients receiving non-cisplatin chemotherapy JO - Acta Oncol VL - 35 UR - https://doi.org/10.3109/02841869609098496 DO - 10.3109/02841869609098496 ID - Jørgensen1996 ER - TY - JOUR AU - Numbenjapon, T. AU - Sriswasdi, C. AU - Mongkonsritragoon, W. AU - Leelasiri, A. AU - Prayoonwiwat, W. PY - 2002 DA - 2002// TI - Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma JO - J Med Assoc Thail VL - 85 ID - Numbenjapon2002 ER - TY - JOUR AU - Saito, M. AU - Aogi, K. AU - Sekine, I. AU - Yoshizawa, H. AU - Yanagita, Y. AU - Sakai, H. AU - Inoue, K. AU - Kitagawa, C. AU - Ogura, T. AU - Mitsuhashi, S. PY - 2009 DA - 2009// TI - Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(08)70313-9 DO - 10.1016/S1470-2045(08)70313-9 ID - Saito2009 ER - TY - JOUR AU - Suzuki, K. AU - Yamanaka, T. AU - Hashimoto, H. AU - Shimada, Y. AU - Arata, K. AU - Matsui, R. AU - Goto, K. AU - Takiguchi, T. AU - Ohyanagi, F. AU - Kogure, Y. AU - Nogami, N. AU - Nakao, M. AU - Takeda, K. AU - Azuma, K. AU - Nagase, S. AU - Hayashi, T. AU - Fujiwara, K. AU - Shimada, T. AU - Seki, N. AU - Yamamoto, N. PY - 2016 DA - 2016// TI - Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw220 DO - 10.1093/annonc/mdw220 ID - Suzuki2016 ER - TY - JOUR AU - Kubota, K. AU - Saito, M. AU - Aogi, K. AU - Sekine, I. AU - Yoshizawa, H. AU - Yanagita, Y. AU - Sakai, H. AU - Inoue, K. AU - Kitagawa, C. AU - Ogura, T. PY - 2016 DA - 2016// TI - Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens JO - Support Care Cancer VL - 24 UR - https://doi.org/10.1007/s00520-016-3203-5 DO - 10.1007/s00520-016-3203-5 ID - Kubota2016 ER - TY - JOUR AU - Roila, F. AU - Herrstedt, J. AU - Aapro, M. AU - Gralla, R. J. AU - Einhorn, L. H. AU - Ballatori, E. AU - Bria, E. AU - Clark-Snow, R. A. AU - Espersen, B. T. AU - Feyer, P. AU - Grunberg, S. M. AU - Hesketh, P. J. AU - Jordan, K. AU - Kris, M. G. AU - Maranzano, E. AU - Molassiotis, A. AU - Morrow, G. AU - Olver, I. AU - Rapoport, B. L. AU - Rittenberg, C. AU - Saito, M. AU - Tonato, M. AU - Warr, D. PY - 2010 DA - 2010// TI - Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq194 DO - 10.1093/annonc/mdq194 ID - Roila2010 ER - TY - JOUR AU - Vardy, J. AU - Chiew, K. S. AU - Galica, J. AU - Pond, G. R. AU - Tannock, I. F. PY - 2006 DA - 2006// TI - Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy JO - Br J Cancer VL - 94 UR - https://doi.org/10.1038/sj.bjc.6603048 DO - 10.1038/sj.bjc.6603048 ID - Vardy2006 ER - TY - JOUR AU - Aapro, M. AU - Fabi, A. AU - Nole, F. AU - Medici, M. AU - Steger, G. AU - Bachmann, C. AU - Roncoroni, S. AU - Roila, F. PY - 2010 DA - 2010// TI - Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdp584 DO - 10.1093/annonc/mdp584 ID - Aapro2010 ER - TY - JOUR AU - Grunberg, S. M. PY - 2007 DA - 2007// TI - Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis JO - Ann Oncol VL - 18 UR - https://doi.org/10.1093/annonc/mdl347 DO - 10.1093/annonc/mdl347 ID - Grunberg2007 ER - TY - JOUR AU - Herrstedt, J. AU - Roila, F. AU - Warr, D. AU - Celio, L. AU - Navari, R. M. AU - Hesketh, P. J. AU - Chan, A. AU - Aapro, M. S. PY - 2016 DA - 2016// TI - Updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high emetic risk chemotherapy JO - Support Care Cancer VL - 2017 ID - Herrstedt2016 ER - TY - JOUR AU - Majumdar, A. K. AU - McCrea, J. B. AU - Panebianco, D. L. AU - Hesney, M. AU - Dru, J. AU - Constanzer, M. AU - Goldberg, M. R. AU - Murphy, G. AU - Gottesdiener, K. M. AU - Lines, C. R. AU - Petty, K. J. AU - Blum, R. A. PY - 2003 DA - 2003// TI - Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe JO - Clin Pharmacol Ther VL - 74 UR - https://doi.org/10.1016/S0009-9236(03)00123-1 DO - 10.1016/S0009-9236(03)00123-1 ID - Majumdar2003 ER - TY - JOUR AU - Georgy, A. AU - Neceskas, J. AU - Goodin, S. PY - 2007 DA - 2007// TI - Antiemetic care for patients with breast cancer: focus on drug interactions and safety concerns JO - Am J Health Syst Pharm VL - 64 UR - https://doi.org/10.2146/ajhp060609 DO - 10.2146/ajhp060609 ID - Georgy2007 ER - TY - JOUR AU - Aapro, M. S. AU - Walko, C. M. PY - 2010 DA - 2010// TI - Aprepitant: drug-drug interactions in perspective JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq149 DO - 10.1093/annonc/mdq149 ID - Aapro2010 ER - TY - JOUR AU - Hesketh, P. J. AU - Aapro, M. AU - Street, J. C. AU - Carides, A. D. PY - 2010 DA - 2010// TI - Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy JO - Support Care Cancer VL - 18 UR - https://doi.org/10.1007/s00520-009-0737-9 DO - 10.1007/s00520-009-0737-9 ID - Hesketh2010 ER - TY - JOUR AU - Warr, D. G. AU - Street, J. C. AU - Carides, A. D. PY - 2011 DA - 2011// TI - Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin-cyclophosphamide-based chemotherapy JO - Support Care Cancer VL - 19 UR - https://doi.org/10.1007/s00520-010-0899-5 DO - 10.1007/s00520-010-0899-5 ID - Warr2011 ER - TY - JOUR AU - Machu, T. K. PY - 2011 DA - 2011// TI - Therapeutics of 5-HT3 receptor antagonists: current uses and future directions JO - Pharmacol Ther VL - 130 UR - https://doi.org/10.1016/j.pharmthera.2011.02.003 DO - 10.1016/j.pharmthera.2011.02.003 ID - Machu2011 ER - TY - JOUR AU - Herr, N. AU - Bode, C. AU - Duerschmied, D. PY - 2017 DA - 2017// TI - The effects of serotonin in immune cells JO - Front Cardiovasc Med VL - 4 UR - https://doi.org/10.3389/fcvm.2017.00048 DO - 10.3389/fcvm.2017.00048 ID - Herr2017 ER - TY - JOUR AU - Shajib, M. S. AU - Khan, W. I. PY - 2015 DA - 2015// TI - The role of serotonin and its receptors in activation of immune responses and inflammation JO - Acta Physiol (Oxf) VL - 213 UR - https://doi.org/10.1111/apha.12430 DO - 10.1111/apha.12430 ID - Shajib2015 ER - TY - JOUR AU - Maemondo, M. AU - Masuda, N. AU - Sekine, I. AU - Kubota, K. AU - Segawa, Y. AU - Shibuya, M. AU - Imamura, F. AU - Katakami, N. AU - Hida, T. AU - Takeo, S. PY - 2009 DA - 2009// TI - A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdp195 DO - 10.1093/annonc/mdp195 ID - Maemondo2009 ER -